跳至主要内容
临床试验/CTRI/2022/07/044500
CTRI/2022/07/044500尚未招募未知

Adult BCG revaccination induced Antibody and cTfh responses in Latent Tuberculosis individuals with or without diabetes mellitus

Department of Biotechnology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Screening phase:
  • Willingness to undergo HIV testing.
  • Willingness to receive either intradermal BCG vaccine or placebo inoculation.
  • Willingness to provide repeat venous blood samples at D-3, D0 (the day of BCG or placebo inoculation), D7, D14, D28 and D56.
  • Willingness to have samples and data stored.
  • Able to provide informed consent.
  • Study phase:
  • Individuals are eligible for the study phase if they meet the requirements for one of the study groups, as follows:
  • Type 1 and 2 Diabetes will be included in the study. We cannot differentiate between Type1 and Type 2 diabetes based on HbA1c.
  • Group I: Latent tuberculosis infection (LTBI) negative long-term controllers no Diabetes mellitus (DM);
  • Group II: LTBI without Diabetes mellitus (DM);
  • Group III: LTBI Negative with Diabetes mellitus (DM); and
  • Group IV: LTBI with Diabetes mellitus (DM).

排除标准

  • 未提供

研究者

发起方
Department of Biotechnology

相似试验